Peer-reviewed veterinary case report
Robot-assisted sacrocolpopexy for pelvic organ prolapse and urinary
By Gotoh D et al.·2026·Department of Urology, Japan·View original on Europe PMC →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Robot-assisted Sacrocolpopexy Efficacy and Safety for Lower Urinary Tract Dysfunction Associated With Pelvic Organ Prolapse.
Plain-English summary
This study looked at how effective and safe a robotic surgery called sacrocolpopexy is for women with pelvic organ prolapse (when the bladder, uterus, or rectum drops into the vagina) and related lower urinary tract problems. Researchers followed 23 women, averaging 74 years old, who had this surgery and found that their urinary symptoms and quality of life improved significantly within weeks after the procedure. They also noticed that the amount of urine left in the bladder after going to the bathroom decreased, which is a good sign. While there were some complications, like urinary incontinence in a couple of patients and one case of intestinal blockage, the overall results suggest that this surgery can be a helpful option for women dealing with these issues. In summary, the treatment worked well for most patients, improving their symptoms and quality of life.
Abstract
<h4>Background/aim</h4>Pelvic organ prolapse (POP) is a condition in which the bladder, uterus, or rectum prolapses from the vagina. Assessing the presence or absence of POP is important when examining for lower urinary tract dysfunction (LUTD) in women. However, reports on changes in LUTD before and after robot-assisted sacrocolpopexy (RSC) are scarce. This study aimed to explore the progression of LUTD after RSC for POP.<h4>Patients and methods</h4>Patients with POP who underwent RSC at the Department of Urology, Nara Medical University, between July 1, 2021, and September 30, 2024, were enrolled. Patient background, perioperative uroflowmetry results, treatment efficacy, and safety were retrospectively evaluated.<h4>Results</h4>In total, 23 patients were included in the study, with a median age of 74.0 years at the time of surgery. The total international prostate symptom score and quality of life scores were significantly lower at 4 weeks after surgery than at baseline and continued to decrease at 12 and 24 weeks. The maximum flow rate was significantly higher at 4 weeks after surgery than at baseline and continued to increase at 12 and 24 weeks. The post-void residual urine volume was significantly lower at 4 weeks after surgery than at baseline and continued to decrease at 12 and 24 weeks. Postoperative complications included urinary incontinence (grade II and IIIb) in two patients and intestinal obstruction (grade IIIb) in one patient. Two cases of stage II recurrence were identified, but after consultation with the patients, no reoperation was performed.<h4>Conclusion</h4>RSC appears to be a clinically useful option for pelvic organ prolapse with concomitant lower urinary tract dysfunction, providing meaningful postoperative functional improvement with an acceptable safety profile. Larger comparative studies with longer follow up are needed to confirm durability and better define patient selection and complication prevention.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Europe PMC: https://europepmc.org/article/MED/41760311